Literature DB >> 30430560

The immunopathogenesis of fibrosis in systemic sclerosis.

M Brown1, S O'Reilly1.   

Abstract

Systemic sclerosis (SSc) is an idiopathic systemic autoimmune disease. It is characterized by a triad of hallmarks: immune dysfunction, fibrosis and vasculopathy. Immune dysfunction in SSc is characterized by the activation and recruitment of immune cells and the production of autoantibodies and cytokines. How immune abnormalities link the fibrosis and vasculopathy in SSc is poorly understood. A plethora of immune cell types are implicated in the immunopathogenesis of SSc, including T cells, B cells, dendritic cells, mast cells and macrophages. How these different cell types interact to contribute to SSc is complicated, and can involve cell-to-cell interactions and communication via cytokines, including transforming growth factor (TGF)-β, interleukin (IL)-6 and IL-4. We will attempt to review significant and recent research demonstrating the importance of immune cell regulation in the immunopathogenesis of SSc with a particular focus on fibrosis.
© 2018 British Society for Immunology.

Entities:  

Keywords:  B cells; T cells; Toll-like receptors (TLRs); arthritis (including rheumatoid arthritis)

Mesh:

Substances:

Year:  2018        PMID: 30430560      PMCID: PMC6378383          DOI: 10.1111/cei.13238

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis.

Authors:  Xinyu Ma; Rui Tang; Mei Luo; Zhuotong Zeng; Yaqian Shi; Bingsi Tang; Rong Xiao
Journal:  Clin Rheumatol       Date:  2021-06-02       Impact factor: 2.980

Review 2.  Tumor-derived exosomes in the regulation of macrophage polarization.

Authors:  Mirza S Baig; Anjali Roy; Sajjan Rajpoot; Dongfang Liu; Rajkumar Savai; Sreeparna Banerjee; Manabu Kawada; Syed M Faisal; Rohit Saluja; Uzma Saqib; Tomokazu Ohishi; Kishore K Wary
Journal:  Inflamm Res       Date:  2020-03-11       Impact factor: 4.575

3.  Systematic comparisons of various markers for mast cell activation in RBL-2H3 cells.

Authors:  Chuda Rujitharanawong; Sunisa Yoodee; Kanyarat Sueksakit; Paleerath Peerapen; Papapit Tuchinda; Kanokvalai Kulthanan; Visith Thongboonkerd
Journal:  Cell Tissue Res       Date:  2022-09-20       Impact factor: 4.051

4.  Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile.

Authors:  Brian Skaug; Dinesh Khanna; William R Swindell; Monique E Hinchcliff; Tracy M Frech; Virginia D Steen; Faye N Hant; Jessica K Gordon; Ami A Shah; Lisha Zhu; W Jim Zheng; Jeffrey L Browning; Alexander M S Barron; Minghua Wu; Sudha Visvanathan; Patrick Baum; Jennifer M Franks; Michael L Whitfield; Victoria K Shanmugam; Robyn T Domsic; Flavia V Castelino; Elana J Bernstein; Nancy Wareing; Marka A Lyons; Jun Ying; Julio Charles; Maureen D Mayes; Shervin Assassi
Journal:  Ann Rheum Dis       Date:  2019-11-25       Impact factor: 19.103

Review 5.  The role of mast cells in human skin cancers.

Authors:  Domenico Ribatti; Roberto Tamma; Tiziana Annese; Enrico Crivellato
Journal:  Clin Exp Med       Date:  2021-02-12       Impact factor: 3.984

6.  Abnormal expression of interleukin-6 is associated with epidermal alternations in localized scleroderma.

Authors:  Xingyu Zhu; Liuyiqi Jiang; Qian Zhong; Xiangzhen Kong; Rui Zhang; Lingxian Zhu; Qingmei Liu; Wenyu Wu; Yimei Tan; Jiucun Wang; Jingjing Xia
Journal:  Clin Rheumatol       Date:  2022-03-12       Impact factor: 2.980

7.  Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial.

Authors:  Roham T Zamanian; David Badesch; Lorinda Chung; Robyn T Domsic; Thomas Medsger; Ashley Pinckney; Lynette Keyes-Elstein; Carla D'Aveta; Meagan Spychala; R James White; Paul M Hassoun; Fernando Torres; Andrew J Sweatt; Jerry A Molitor; Dinesh Khanna; Holden Maecker; Beverly Welch; Ellen Goldmuntz; Mark R Nicolls
Journal:  Am J Respir Crit Care Med       Date:  2021-07-15       Impact factor: 30.528

Review 8.  Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders.

Authors:  Alexandros Marios Sofias; Federica De Lorenzi; Quim Peña; Armin Azadkhah Shalmani; Mihael Vucur; Jiong-Wei Wang; Fabian Kiessling; Yang Shi; Lorena Consolino; Gert Storm; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2021-06-15       Impact factor: 15.470

Review 9.  An update on targeted therapies in systemic sclerosis based on a systematic review from the last 3 years.

Authors:  Corrado Campochiaro; Yannick Allanore
Journal:  Arthritis Res Ther       Date:  2021-06-01       Impact factor: 5.156

10.  Identification of Potential ceRNA Network and Patterns of Immune Cell Infiltration in Systemic Sclerosis-Associated Interstitial Lung Disease.

Authors:  Qiuhong Wu; Yang Liu; Yan Xie; Shixiong Wei; Yi Liu
Journal:  Front Cell Dev Biol       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.